As bioprocessing teams explore perfusion to increase productivity and extend culture duration, they need a development platform that makes evaluation simple, scalable, and data-rich.
Our latest Technical Bulletin demonstrates the expanded potential of high-density TFF perfusion on the Stratyx™ platform through a controlled side-by-side comparison with fed-batch. Using the same CHO cell line, inoculum, and operating conditions, TFF perfusion delivered compelling improvements across every major productivity metric.
Study Highlights
These results demonstrate how Stratyx can support the evaluation of high-density perfusion alongside traditional fed-batch workflows on a single automated platform, giving process development teams the flexibility to compare strategies while capturing comprehensive process data.
Download the Technical Bulletin to explore the complete study, methodology, and performance results.